Heart disease is the leading cause of death in the United States, and doctors suggest you might benefit from monitoring your ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Medical experts said such an innovative monitoring method, may significantly enhance patients' compliance to blood glucose monitoring regularly and improve their quality of life.

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Researchers have devised a revolutionary, noninvasive method to monitor blood glucose, allowing for accurate measurements of ...

New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms ...

A three-year, $1.4m project aims to address inequities experienced by Māori and Pacific people with type 1 diabetes.

According to a new market research report titled ' Network Monitoring Market by Offering (Equipment, Software, Services), ...

REDDING, Calif., Jan. 30, 2025 /PRNewswire/ -- According to a new market research report titled ' Network Monitoring Market by Offering (Equipment, Software, Services), Technology (Ethernet, Fiber ...

With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...

The global patient monitoring market size was valued at USD 55.60 billion in 2024 and is projected to reach from USD 59.66 billion in 2025 to USD 112.47 billion by 2033, growing at a CAGR of 7.3% ...